Země: Irsko
Jazyk: angličtina
Zdroj: HPRA (Health Products Regulatory Authority)
Ciprofloxacin lactate
Pfizer Healthcare Ireland
J01MA; J01MA02
Ciprofloxacin lactate
2 milligram(s)/millilitre
Solution for infusion
Fluoroquinolones; ciprofloxacin
Not marketed
2007-06-01
Page 1 of 12 2021-0066912 PACKAGE LEAFLET: INFORMATION FOR THE USER CIPROFLOXACIN 2 MG/ML SOLUTION FOR INFUSION Ciprofloxacin READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU ARE GIVEN THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor or pharmacist. - This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. - If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET 1. What Ciprofloxacin is and what it is used for 2. What you need to know before you are given Ciprofloxacin 3. How to use Ciprofloxacin 4. Possible side effects 5. How to store Ciprofloxacin 6. Contents of the pack and other information 1. WHAT CIPROFLOXACIN IS AND WHAT IT IS USED FOR Ciprofloxacin contains the active substance Ciprofloxacin. Ciprofloxacin is an antibiotic belonging to the fluoroquinolone family. Ciprofloxacin works by killing bacteria that cause infections. It only works with specific strains of bacteria. Adults Ciprofloxacin is used in adults to treat the following bacterial infections: • respiratory tract infections • long lasting or recurring ear or sinus infections • urinary tract infections • genital tract infections in men and women • gastro-intestinal tract infections and intra-abdominal infections • skin and soft tissue infections • bone and joint infections • anthrax inhalation exposure Ciprofloxacin may be used in the management of patients with low white blood cell counts (neutropenia) who have a fever that is suspected to be due to a bacterial infection. If you have a severe infection or one that is caused by more than one type of bacterium, you may be given additional antibiotic treatment in addition to Ciprofloxacin. Page 2 of 12 2021-0066912 Children and adolescents Ciprofloxacin is use Přečtěte si celý dokument
Health Products Regulatory Authority 12 August 2021 CRN00CD0X Page 1 of 21 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Ciprofloxacin 2 mg/ml solution for infusion 2 QUALITATIVE AND QUANTITATIVE COMPOSITION 1 ml solution for infusion contains: 2 mg ciprofloxacin (as ciprofloxacin lactate). Excipients with known effect: 1 ml solution contains: 50 mg glucose monohydrate: equivalent to 45 mg glucose. For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Solution for infusion. Clear, colourless or slightly yellow solution. The pH-value of the solution for infusion ranges from 3.9 to 4.5. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Ciprofloxacin solution for infusion is indicated for the treatment of the following infections (see sections 4.4 and 5.1). Special attention should be paid to available information on resistance to ciprofloxacin before commencing therapy. Consideration should be given to official guidance on the appropriate use of antibacterial agents. Adults Lower respiratory tract infections due to Gram-negative bacteria - exacerbation of chronic obstructive pulmonary disease In exacerbation of chronic obstructive pulmonary disease Ciprofloxacin should be used only when it is considered inappropriate to use other antibacterial agents that are commonly recommended for the treatment of these infections. - broncho-pulmonary infections in cystic fibrosis or in bronchiectasis - pneumonia Chronic suppurative otitis media Acute exacerbation of chronic sinusitis especially if these are caused by Gram-negative bacteria Urinary tract infections - Acute pyelonephritis - Complicated pyelonephritis Bacterial prostatitis Genital tract infections - epididymo-orchitis including cases due to susceptible _Neisseria gonorrhoeae_ - pelvic inflammatory disease including cases due to susceptible _Neisseria gonorrhoeae_ Infections of the gastrointestinal tract (e.g. travellers` diarrhoea) Intra-abdominal infections Infections of the skin and soft Přečtěte si celý dokument